Home › Funds › VIKING GLOBAL INVESTORS LP › ROIV
VIKING GLOBAL INVESTORS LP position in ROIV
ROIVANT SCIENCES LTD · Health Care
VIKING GLOBAL INVESTORS LP reported holding 6,757,326 shares of ROIV (ROIVANT SCIENCES LTD) in its Q3 2026 13F filing — a position valued at US$247.1M, representing 0.76% of its reported portfolio and ranking #46 among its reported holdings. VIKING GLOBAL INVESTORS LP has disclosed ROIV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How VIKING GLOBAL INVESTORS LP's ROIV position evolved
VIKING GLOBAL INVESTORS LP first disclosed a stake in ROIV in Q3 2023 at 73,434,301 shares (US$857.7M). Across 13 filings, VIKING GLOBAL INVESTORS LP increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 6,757,326 shares valued at US$247.1M — an increase of 485,859 shares quarter over quarter.. Notable position changes include a 26% trim in Q2 2025 (shares rose 34% over the following quarter), a 31% trim in Q3 2025 (shares rose 43% over the following quarter), a 73% trim in Q4 2025 (shares rose 28% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 73.43M | $857.71M | New |
| Q4 2023 | 69.37M | $779.01M | Reduce |
| Q1 2024 | 69.37M | $731.15M | Hold |
| Q2 2024 | 69.16M | $730.98M | Hold |
| Q3 2024 | 54.10M | $624.30M | Reduce |
| Q4 2024 | 47.81M | $565.59M | Reduce |
| Q1 2025 | 46.01M | $464.28M | Reduce |
| Q2 2025 | 34.24M | $385.86M | Reduce |
| Q3 2025 | 23.59M | $356.99M | Reduce |
| Q4 2025 | 6.44M | $139.82M | Reduce |
| Q1 2026 | 6.65M | $184.27M | Add |
| Q2 2026 | 6.27M | $221.95M | Reduce |
| Q3 2026 | 6.76M | $247.12M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ROIV and 13F data
ROIV (ROIVANT SCIENCES LTD) is a Health Care company. 53 other funds we track also report a position in ROIV — the largest reported positions include QVT Financial LP (US$867.6M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$795.2M), Farallon Capital Management (US$506.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ROIV
- QVT Financial LP 23.72M sh · $867.55M · Q3 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 21.75M sh · $795.23M · Q3 2026
- Farallon Capital Management 14.31M sh · $506.40M · Q2 2026
- ADAGE CAPITAL PARTNERS GP, L.L.C. 11.00M sh · $402.28M · Q3 2026
- Patient Square Capital LP 7.71M sh · $281.99M · Q3 2026
- Rubric Capital Management LP 7.48M sh · $273.60M · Q3 2026
- Darwin Global Management, Ltd. 6.75M sh · $246.75M · Q3 2026
- PERCEPTIVE ADVISORS LLC 6.51M sh · $238.11M · Q3 2026
- Nearwater Capital Markets, Ltd 5.60M sh · $204.79M · Q3 2026
- BAKER BROS. ADVISORS LP 3.66M sh · $133.86M · Q3 2026
- Affinity Asset Advisors, LLC 3.20M sh · $117.02M · Q3 2026
- ADAR1 Capital Management, LLC 3.08M sh · $112.62M · Q3 2026
More on VIKING GLOBAL INVESTORS LP
FAQ
How long has VIKING GLOBAL INVESTORS LP held ROIV?
VIKING GLOBAL INVESTORS LP has disclosed ROIV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is VIKING GLOBAL INVESTORS LP's current position in ROIV?
As of Q3 2026, VIKING GLOBAL INVESTORS LP holds 6.76M shares of ROIV (ROIVANT SCIENCES LTD), valued at $247.12M, representing 0.76% of its reported portfolio and ranking #46.
Has VIKING GLOBAL INVESTORS LP been buying or selling ROIV?
In the latest 13F filing (Q3 2026), VIKING GLOBAL INVESTORS LP increased its position in ROIV.
Which other funds hold ROIV?
Other major institutional holders of ROIV include QVT Financial LP, FARALLON CAPITAL MANAGEMENT, L.L.C., Farallon Capital Management, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.